,S_name,O_name,label,title,from,to,arrows,color,id
1,Intercellular adhesion molecule 1,Malignant neoplasm of liver,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10037274' target='_blank'>The ICAM-1       concentration in HCC (13.43+/-0.09) was higher than that in tumor surrounding the       liver (5.89+/-0.17, P < 0.01) and that in normal liver (4.27+/-0.21, P < 0.01).</br></a><font color='red'>ICAM-1</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",0,132,to,PREP,0
2,Intercellular adhesion molecule 1,Malignant neoplasm of liver,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10037274' target='_blank'>Northern blot analysis revealed that ICAM-1 expression, as indicated       by mRNA level, was also higher in HCC and in cancer emboli than in tumor       surrounding liver and normal liver.</br></a><font color='red'>ICAM-1</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",0,132,to,PREP,1
3,Hepatocarcinogenesis,DNA hypermethylation,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10051471' target='_blank'>DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are       associated with hepatocarcinogenesis.</br></a><font color='red'>hepatocarcinogenesis</font> <font color='blue'>associated </font> <font color='green'>DNA hypermethylation</font></p>,1,133,to,VERB,2
4,Candidate Tumor Suppressor Gene,Liver and Intrahepatic Biliary Tract Carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10051471' target='_blank'>To examine the significance of aberrant DNA methylation in hepatocarcinogenesis,        the DNA methylation status at the D17S5 locus and mRNA expression of a candidate        tumor suppressor gene, HIC-1 (hypermethylated-in-cancer), which was identified at       the D17S5 locus, in primary hepatocellular carcinomas (HCCs) and their       corresponding noncancerous liver tissues were assessed.</br></a><font color='red'>candidate        tumor suppressor gene</font> <font color='blue'>in </font> <font color='green'>primary hepatocellular carcinomas</font></p>",2,134,to,PREP,3
5,Locus,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10051471' target='_blank'>The incidence of DNA hypermethylation at this       locus was significantly higher in HCCs (90%) than noncancerous liver tissues (P       <.001).</br></a><font color='red'>locus</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>,3,106,to,PREP,4
6,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10051471' target='_blank'>Moreover,       wild-type p53 did not overcome DNA hypermethylation at the D17S5 locus to       activate HIC-1 in HCCs.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",4,106,to,PREP,5
7,"RNA, Messenger",Hepatoblastoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10076051' target='_blank'>HGFLP mRNA was also       found to be overexpressed in a hepatoblastoma sample and in a sample of subacute        fulminant hepatic necrosis.</br></a><font color='red'>mRNA</font> <font color='blue'>in </font> <font color='green'>hepatoblastoma</font></p>,5,135,to,PREP,6
8,multidrug resistance-associated protein 2,Neuroblastoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver       tumors and its relevance to clinical behavior.</br></a><font color='red'>cMOAT</font> <font color='blue'>in </font> <font color='green'>neuroblastomas</font></p>,6,136,to,PREP,7
9,multidrug resistance-associated protein 2,Malignant neoplasm of liver,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver       tumors and its relevance to clinical behavior.</br></a><font color='red'>cMOAT</font> <font color='blue'>in </font> <font color='green'>malignant liver       tumors</font></p>,6,132,to,PREP,8
10,Multidrug Resistance Associated Protein 1,Neuroblastoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver       tumors and its relevance to clinical behavior.</br></a><font color='red'>MRP</font> <font color='blue'>in </font> <font color='green'>neuroblastomas</font></p>,7,136,to,PREP,9
11,Multidrug Resistance Associated Protein 1,Malignant neoplasm of liver,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver       tumors and its relevance to clinical behavior.</br></a><font color='red'>MRP</font> <font color='blue'>in </font> <font color='green'>malignant liver       tumors</font></p>,7,132,to,PREP,10
12,multidrug resistance-associated protein 2,childhood hepatocellular carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>The       expression of MRP and cMOAT in the childhood liver tumors was more common and       higher, especially in advanced cases with a poor outcome, than that observed in       normal liver or in 9 hepatocellular carcinomas from adult patients.</br></a><font color='red'>cMOAT</font> <font color='blue'>in </font> <font color='green'>childhood liver tumors</font></p>",6,137,to,PREP,11
13,Multidrug Resistance Associated Protein 1,childhood hepatocellular carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10081488' target='_blank'>The       expression of MRP and cMOAT in the childhood liver tumors was more common and       higher, especially in advanced cases with a poor outcome, than that observed in       normal liver or in 9 hepatocellular carcinomas from adult patients.</br></a><font color='red'>MRP</font> <font color='blue'>in </font> <font color='green'>childhood liver tumors</font></p>",7,137,to,PREP,12
14,WT-1,Neoplastic Cell Transformation,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10189890' target='_blank'>To determine the role of the Wilms' tumor gene WT1 in tumorigenesis of solid       tumors, expression of the WT1 gene was examined in 34 solid tumor cell lines       (four gastric cancer cell lines, five colon cancer cell lines, 15 lung cancer       cell lines, four breast cancer cell lines, one germ cell tumor cell line, two       ovarian cancer cell lines, one uterine cancer cell line, one thyroid cancer cell        line, and one hepatocellular carcinoma cell line) by means of quantitative       reverse transcriptase-polymerase chain reaction.</br></a><font color='red'>WT1</font> <font color='blue'>role </font> <font color='green'>tumorigenesis</font></p>",8,113,to,NOM,13
15,solid tumor,Growth,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10189890' target='_blank'>These results indicated that the WT1 gene       plays an essential role in the growth of solid tumors and performs an oncogenic       rather than a tumor-suppressor gene function.</br></a><font color='red'>solid tumors</font> <font color='blue'>plays an essential role </font> <font color='green'>growth</font></p>,9,138,to,COMPLEX,14
16,FUSE gene,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10190313' target='_blank'>This study explores the use of a liver-specific albumin promoter and a       tumor-specific alpha-fetoprotein (AFP) enhancer to achieve the regulated       expression of the cytokine interleukin-2/interferon alpha2b (IL-2/IFNalpha2b)       fused gene for treatment of hepatocellular carcinoma (HCC).</br></a><font color='red'>fused gene</font> <font color='blue'>treatment </font> <font color='green'>hepatocellular carcinoma</font></p>,10,106,to,NOM,15
17,Autoantigens,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10190901' target='_blank'>A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human       hepatocellular carcinoma.</br></a><font color='red'>autoantigen</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,11,106,to,PREP,16
18,APC gene,Malignant tumor of colon,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutations in the adenomatous polyposis coli (APC) tumour-suppressor gene occur in       most human colon cancers.</br></a><font color='red'>adenomatous polyposis coli</font> <font color='blue'>adenomatous polyposis coli (APC) tumour-suppressor gene </font> <font color='green'>colon cancers</font></p>,12,139,to,INFER,17
19,Tumor Suppressor Genes,Malignant tumor of colon,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutations in the adenomatous polyposis coli (APC) tumour-suppressor gene occur in       most human colon cancers.</br></a><font color='red'>tumour-suppressor gene</font> <font color='blue'>in </font> <font color='green'>colon cancers</font></p>,13,139,to,PREP,18
20,CTNNB1 gene,Malignant tumor of colon,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutant forms of beta-catenin have been discovered       in colon cancers that retain wild-type APC genes, and also in melanomas,       medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas.</br></a><font color='red'>beta-catenin</font> <font color='blue'>in </font> <font color='green'>colon cancers</font></p>",14,139,to,PREP,19
21,APC gene,Medulloblastoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutant forms of beta-catenin have been discovered       in colon cancers that retain wild-type APC genes, and also in melanomas,       medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas.</br></a><font color='red'>APC genes</font> <font color='blue'>in </font> <font color='green'>medulloblastomas</font></p>",12,140,to,PREP,20
22,APC gene,melanoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutant forms of beta-catenin have been discovered       in colon cancers that retain wild-type APC genes, and also in melanomas,       medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas.</br></a><font color='red'>APC genes</font> <font color='blue'>in </font> <font color='green'>melanomas</font></p>",12,141,to,PREP,21
23,APC gene,Malignant neoplasm of prostate,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutant forms of beta-catenin have been discovered       in colon cancers that retain wild-type APC genes, and also in melanomas,       medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas.</br></a><font color='red'>APC genes</font> <font color='blue'>in </font> <font color='green'>prostate cancer</font></p>",12,142,to,PREP,22
24,APC gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10201372' target='_blank'>Mutant forms of beta-catenin have been discovered       in colon cancers that retain wild-type APC genes, and also in melanomas,       medulloblastomas, prostate cancer and gastric and hepatocellular carcinomas.</br></a><font color='red'>APC genes</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>",12,106,to,PREP,23
25,Hepatitis B Antigens,Hepatocarcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10208429' target='_blank'>The translation initiation factor, hu-Sui1 may be a target of hepatitis B X       antigen in hepatocarcinogenesis.</br></a><font color='red'>hepatitis B X       antigen</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>",15,1,to,PREP,24
26,Cytotoxic Chemotherapy,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10209305' target='_blank'>Classical cytotoxic therapy has been minimally useful in the treatment of       hepatocellular carcinoma.</br></a><font color='red'>cytotoxic therapy</font> <font color='blue'>treatment </font> <font color='green'>hepatocellular carcinoma</font></p>,16,106,to,NOM,25
27,Signal Transduction Pathways,Growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10209305' target='_blank'>In an effort to develop a new approach to the treatment       of this neoplasm, we have investigated the signal transduction pathways       regulating the growth of human hepatoma cells.</br></a><font color='red'>signal transduction pathways</font> <font color='blue'>regulating </font> <font color='green'>growth</font></p>",17,138,to,VERB,26
28,Pathogenesis,Proliferating Cell Nuclear Antigen,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10209305' target='_blank'>Furthermore, cyclin A deregulation has been implicated in the pathogenesis of       hepatocellular carcinoma.</br></a><font color='red'>pathogenesis</font> <font color='blue'>implicated </font> <font color='green'>cyclin</font></p>",18,143,to,VERB,27
29,"INSR protein, human",Liver diseases,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10210639' target='_blank'>Human insulin receptor and insulin signaling proteins in hepatic disease.</br></a><font color='red'>Human insulin receptor</font> <font color='blue'>in </font> <font color='green'>hepatic disease</font></p>,19,144,to,PREP,28
30,insulin receptor substrate 1 protein,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10210639' target='_blank'>Although an altered       mass of IRS-1 protein was not observed in HCC, an IRS-1 increase in cirrhosis may       favor hepatic regeneration.</br></a><font color='red'>IRS-1 protein</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",20,106,to,PREP,29
31,PROC wt Allele,Intrahepatic Cholangiocarcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10212000' target='_blank'>Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic       cholangiocarcinoma.</br></a><font color='red'>APC</font> <font color='blue'>in </font> <font color='green'>intrahepatic       cholangiocarcinoma</font></p>",21,145,to,PREP,30
32,TP53 gene,Intrahepatic Cholangiocarcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10212000' target='_blank'>The analysis of the clinicopathologic findings disclosed a significant       relationship between the genetic alteration and gross type of the tumor: the p53        mutation was prominent in the ICC of mass-forming type, and K-ras mutation       occurred more frequently in the ICC of periductal extension type (p < 0.05).</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>ICC</font></p>",4,145,to,PREP,31
33,TP53 gene,Growth pattern,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10212000' target='_blank'>These data suggest that each of the examined genes is involved in the development       of ICC and that the p53 and K-ras mutation may play a role in the tumor growth       pattern.</br></a><font color='red'>p53</font> <font color='blue'>play a role </font> <font color='green'>growth       pattern</font></p>,4,146,to,COMPLEX,32
34,Alkaloids,Inflammation,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10223233' target='_blank'>BACKGROUND: Berberine, one of the major constitutents of alkaloids of Coptis       chinensis is frequently utilized in the treatment of inflammation and       liver-related diseases.</br></a><font color='red'>alkaloids</font> <font color='blue'>treatment </font> <font color='green'>inflammation</font></p>",22,147,to,NOM,33
35,Berberine,Homo sapiens,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10223233' target='_blank'>METHODS: Human and murine hepatoma cells       were treated with berberine (0.32, 3.2, 32, and 320 microM), tamoxifen (1       microM), or verapamil (10 microM) for 24 hours.</br></a><font color='red'>berberine</font> <font color='blue'>treated </font> <font color='green'>Human</font></p>",23,148,to,VERB,34
36,CA-19-9 Antigen,Adenocarcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10232599' target='_blank'>The selectin ligand components sialyl Lewis x and       sialyl Lewis a are oncodevelopmental antigens involved in progression of       adenocarcinoma.</br></a><font color='red'>sialyl Lewis a</font> <font color='blue'>selectin ligand components sialyl Lewis x and       sialyl Lewis a are oncodevelopmental antigens </font> <font color='green'>adenocarcinoma</font></p>,24,149,to,INFER,35
37,Selectins,Adenocarcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10232599' target='_blank'>The selectin ligand components sialyl Lewis x and       sialyl Lewis a are oncodevelopmental antigens involved in progression of       adenocarcinoma.</br></a><font color='red'>selectin</font> <font color='blue'>selectin ligand components sialyl Lewis x and       sialyl Lewis a are oncodevelopmental antigens </font> <font color='green'>adenocarcinoma</font></p>,25,149,to,INFER,36
38,Antigens,Adenocarcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10232599' target='_blank'>The selectin ligand components sialyl Lewis x and       sialyl Lewis a are oncodevelopmental antigens involved in progression of       adenocarcinoma.</br></a><font color='red'>antigens</font> <font color='blue'>involved </font> <font color='green'>adenocarcinoma</font></p>,26,149,to,VERB,37
39,Glycoprotein 6-alpha-L-fucosyltransferase,Liver neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10232614' target='_blank'>To understand the biological meaning of the alpha1-6FucT in       hepatoma, especially in terms of metastasis, we established human hepatoma cell       lines, which express high levels of alpha1-6FucT by transfection of the       alpha1-6FucT gene and investigated intrahepatic metastasis after splenic       injection to athymic mice.</br></a><font color='red'>alpha1-6FucT</font> <font color='blue'>in </font> <font color='green'>hepatoma</font></p>",27,74,to,PREP,38
40,TP53 gene,Apoptosis,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10321688' target='_blank'>Mad-overexpression down regulates the malignant growth and p53 mediated apoptosis       in human hepatocellular carcinoma BEL-7404 cells.</br></a><font color='red'>p53</font> <font color='blue'>mediated </font> <font color='green'>apoptosis</font></p>,4,150,to,VERB,39
41,,cell growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10321688' target='_blank'>Thus, Mad proteins may function as a        negative regulator antagonizing c-Myc activity in the control of cell growth and        apoptosis in human hepatocellular carcinoma BEL-7404 cells.</br></a><font color='red'>Myc</font> <font color='blue'>control </font> <font color='green'>cell growth</font></p>",NA,151,to,NOM,40
42,,Apoptosis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10321688' target='_blank'>Thus, Mad proteins may function as a        negative regulator antagonizing c-Myc activity in the control of cell growth and        apoptosis in human hepatocellular carcinoma BEL-7404 cells.</br></a><font color='red'>Myc</font> <font color='blue'>control </font> <font color='green'>apoptosis</font></p>",NA,150,to,NOM,41
43,SMAD4 gene,Colorectal Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10340381' target='_blank'>To clarify       the target of 18qLOH, mutation of Smad4 and Smad2 genes was analysed in 176       colorectal tumors with different stages, including liver metastasis, from 111       sporadic, 52 familial adenomatous polyposis (FAP) and nine hereditary       nonpolyposis colorectal cancer (HNPCC) patients.</br></a><font color='red'>Smad4</font> <font color='blue'>in </font> <font color='green'>colorectal tumors</font></p>",29,152,to,PREP,42
44,SMAD2 gene,Colorectal Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10340381' target='_blank'>To clarify       the target of 18qLOH, mutation of Smad4 and Smad2 genes was analysed in 176       colorectal tumors with different stages, including liver metastasis, from 111       sporadic, 52 familial adenomatous polyposis (FAP) and nine hereditary       nonpolyposis colorectal cancer (HNPCC) patients.</br></a><font color='red'>Smad2 genes</font> <font color='blue'>in </font> <font color='green'>colorectal tumors</font></p>",30,152,to,PREP,43
45,SMAD4 gene,Carcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10340381' target='_blank'>The present results suggest that Smad4 gene is one of true targets of        18qLOH, and that its inactivation is involved in advanced stages, such as distant       metastasis, in human colorectal carcinogenesis.</br></a><font color='red'>Smad4 gene</font> <font color='blue'>in </font> <font color='green'>carcinogenesis</font></p>",29,153,to,PREP,44
46,Lung Neoplasms,genotoxicity,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10353384' target='_blank'>For example: (1) ozone-induced lung neoplasms had two unique       mutations, one (codon 61 K-ras CTA mutation) consistent with a direct genotoxic       event and a second (codon 12 K-ras G --> T transversion) consistent with an       indirect genotoxic effect; (2) isoprene-induced Harderian gland neoplasms had a       unique K-ras A --> T transversion at codon 61 which provided evidence that       formation of an epoxide intermediate was involved; (3) 1,3-butadiene-induced       neoplasms had a characteristic K-ras G --> C transversion mutation at codon 13       which was also consistent with a chemical-specific effect; (4) methylene       chloride-induced liver neoplasms had an H-ras mutation profile at codon 61       similar to that of spontaneous tumours, suggesting that methylene chloride       promotes cells with 'spontaneously initiated' ras mutations and (5)       oxazepam-induced liver neoplasms had a low frequency of ras mutations, suggesting       a nonmutagenic pathway of carcinogenesis.</br></a><font color='red'>lung neoplasms</font> <font color='blue'>effect;</font> <font color='green'>genotoxic</font></p>",31,154,to,NOM,45
47,Growth Factor,Liver carcinoma,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>Alterations of oncogenes, tumor suppressor genes and growth factors in       hepatocellular carcinoma: with relation to tumor size and invasiveness.</br></a><font color='red'>growth factors</font> <font color='blue'>Alterations </font> <font color='green'>hepatocellular carcinoma</font></p>",32,106,to,NOM,46
48,Oncogenes,Liver carcinoma,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>Alterations of oncogenes, tumor suppressor genes and growth factors in       hepatocellular carcinoma: with relation to tumor size and invasiveness.</br></a><font color='red'>oncogenes</font> <font color='blue'>Alterations </font> <font color='green'>hepatocellular carcinoma</font></p>",33,106,to,NOM,47
49,Tumor Suppressor Genes,Liver carcinoma,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>Alterations of oncogenes, tumor suppressor genes and growth factors in       hepatocellular carcinoma: with relation to tumor size and invasiveness.</br></a><font color='red'>tumor suppressor genes</font> <font color='blue'>Alterations </font> <font color='green'>hepatocellular carcinoma</font></p>",13,106,to,NOM,48
50,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>RESULTS: The       aberration rates of p53 and CDKN2 in HCC were 45.9% and 36.4% respectively, which       were higher in invasive HCC compared with non-invasive HCC.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",4,106,to,PREP,49
51,CDKN2A gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>RESULTS: The       aberration rates of p53 and CDKN2 in HCC were 45.9% and 36.4% respectively, which       were higher in invasive HCC compared with non-invasive HCC.</br></a><font color='red'>CDKN2</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",34,106,to,PREP,50
52,Transforming Growth Factor alpha,Recurrent Malignant Neoplasm,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>The expression of       EGFR was closely related to TGF-alpha, which was related to HCC recurrence.</br></a><font color='red'>TGF-alpha</font> <font color='blue'>related </font> <font color='green'>recurrence</font></p>",35,155,to,VERB,51
53,Growth Factor,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>The       alterative rates of above-mentioned genes and growth factors in small HCC were       slightly lower than that in large ones, but no significant difference was shown       except the p53 mutation.</br></a><font color='red'>growth factors</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",32,106,to,PREP,52
54,HRAS gene,Recurrent Malignant Neoplasm,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>H-ras       antisense gene might be of potential implication in the control of HCC recurrence       and metastasis.</br></a><font color='red'>H-ras       antisense gene</font> <font color='blue'>control </font> <font color='green'>recurrence</font></p>,36,155,to,NOM,53
55,HRAS gene,Secondary Neoplasm,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10374394' target='_blank'>H-ras       antisense gene might be of potential implication in the control of HCC recurrence       and metastasis.</br></a><font color='red'>H-ras       antisense gene</font> <font color='blue'>control </font> <font color='green'>metastasis</font></p>,36,156,to,NOM,54
56,APC gene,Hepatocarcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10381126' target='_blank'>To define the possible role of mutations of       the APC gene in hepatocarcinogenesis, we examined 46 pairs of hepatocellular       carcinomas and corresponding non-tumorous liver tissue by polymerase chain       reaction and single strand conformation polymorphism.</br></a><font color='red'>APC gene</font> <font color='blue'>role </font> <font color='green'>hepatocarcinogenesis</font></p>",12,1,to,NOM,55
57,TP53 gene,Hereditary hemochromatosis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10381922' target='_blank'>p53 mutations in british patients with hepatocellular carcinoma: clustering in       genetic hemochromatosis.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>genetic hemochromatosis</font></p>,4,157,to,PREP,56
58,TP53 gene,Neoplastic Cell Transformation,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10381922' target='_blank'>We have investigated the role of       p53 mutations in tumorigenesis in British patients with HCC.</br></a><font color='red'>p53</font> <font color='blue'>role </font> <font color='green'>tumorigenesis</font></p>,4,113,to,NOM,57
59,3-nitrotyrosine,Rat Hepatic Neoplasm,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10383909' target='_blank'>Immunohistochemical localization of inducible nitric oxide synthase and       3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.</br></a><font color='red'>3-nitrotyrosine</font> <font color='blue'>in </font> <font color='green'>rat liver tumors</font></p>,37,158,to,PREP,58
60,"NOS2A protein, human",Rat Hepatic Neoplasm,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10383909' target='_blank'>Immunohistochemical localization of inducible nitric oxide synthase and       3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.</br></a><font color='red'>inducible nitric oxide synthase</font> <font color='blue'>in </font> <font color='green'>rat liver tumors</font></p>,38,158,to,PREP,59
61,Oligodeoxyribonucleotides,autocrine,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385405' target='_blank'>Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides       accelerates liver tumor cell proliferation.</br></a><font color='red'>oligodeoxynucleotides</font> <font color='blue'>regulation </font> <font color='green'>autocrine</font></p>,39,159,to,NOM,60
62,activin A,Growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385405' target='_blank'>However, a role of endogenous activin A in local growth modulation has not        been established in any system.</br></a><font color='red'>activin A</font> <font color='blue'>role </font> <font color='green'>growth</font></p>",40,138,to,NOM,61
63,Aim,autocrine,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385405' target='_blank'>The aim of this study was to examine the       production of activin A in the human hepatoma cell line HLF and to explore a       possible autocrine role of activin as a cell growth inhibitor by blocking       production of endogenous activin using antisense oligodeoxynucleotides.</br></a><font color='red'>aim</font> <font color='blue'>role </font> <font color='green'>autocrine</font></p>,41,159,to,NOM,62
64,beta-Chemokines,Malignant neoplasm of liver,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385645' target='_blank'>Expression and function of CXC and CC chemokines in human malignant liver tumors:       a role for human monokine induced by gamma-interferon in lymphocyte recruitment       to hepatocellular carcinoma.</br></a><font color='red'>CC chemokines</font> <font color='blue'>in </font> <font color='green'>malignant liver tumors</font></p>,42,132,to,PREP,63
65,chemokine,Cell Adhesion,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385645' target='_blank'>Chemotactic cytokines (chemokines) play an important role in the recruitment of       lymphocytes to tissue by regulating cellular adhesion and transendothelial       migration.</br></a><font color='red'>Chemotactic cytokines</font> <font color='blue'>regulating </font> <font color='green'>cellular adhesion</font></p>,43,160,to,VERB,64
66,chemokine,Transendothelial Migration,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385645' target='_blank'>Chemotactic cytokines (chemokines) play an important role in the recruitment of       lymphocytes to tissue by regulating cellular adhesion and transendothelial       migration.</br></a><font color='red'>Chemotactic cytokines</font> <font color='blue'>regulating </font> <font color='green'>transendothelial       migration</font></p>,43,161,to,VERB,65
67,Chemokine (C-C Motif) Ligand 4,T-Lymphocyte,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10385645' target='_blank'>This study examined the expression and function of CXC (human monokine       induced by gamma-interferon [HuMig], interleukin-8 [IL-8], and       interferon-inducible protein-10 [IP-10]) and CC (macrophage inflammatory       protein-1alpha [MIP-1alpha], MIP-1beta, regulated upon activation normal T       lymphocyte expressed and secreted (RANTES), and macrophage chemoattractant       protein-1 [MCP-1]) chemokines and their respective receptors on lymphocytes       infiltrating human liver tumors.</br></a><font color='red'>MIP-1beta</font> <font color='blue'>regulated </font> <font color='green'>T       lymphocyte</font></p>",44,162,to,VERB,66
68,MDM2 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>MDM2</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinoma</font></p>",45,106,to,PREP,67
69,FHIT gene,Focal Nodular Hyperplasia,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>FHIT</font> <font color='blue'>in </font> <font color='green'>focal nodular hyperplasia</font></p>",46,163,to,PREP,68
70,FHIT gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>FHIT</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinoma</font></p>",46,106,to,PREP,69
71,GAGE1 wt Allele,Focal Nodular Hyperplasia,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>GAGE-1</font> <font color='blue'>in </font> <font color='green'>focal nodular hyperplasia</font></p>",47,163,to,PREP,70
72,GAGE1 wt Allele,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>GAGE-1</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinoma</font></p>",47,106,to,PREP,71
73,MDM2 gene,Focal Nodular Hyperplasia,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular       carcinoma and focal nodular hyperplasia.</br></a><font color='red'>MDM2</font> <font color='blue'>in </font> <font color='green'>focal nodular hyperplasia</font></p>",45,163,to,PREP,72
74,Tumor Suppressor Genes,Malignant Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Overexpression and/or mutations of oncogenes, tumour suppressor genes and tumour        rejection genes have been observed in several human malignancies.</br></a><font color='red'>tumour suppressor genes</font> <font color='blue'>in </font> <font color='green'>malignancies</font></p>",13,81,to,PREP,73
75,"Genes, Neoplasm",Malignant Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Overexpression and/or mutations of oncogenes, tumour suppressor genes and tumour        rejection genes have been observed in several human malignancies.</br></a><font color='red'>tumour rejection genes</font> <font color='blue'>in </font> <font color='green'>malignancies</font></p>",48,81,to,PREP,74
76,Exons,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Different patterns of non-mutant FHIT transcripts including precise deletion of       exons were found in 7/10 HCC, 2/10 FNH and 2/10 HC.</br></a><font color='red'>exons</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",49,106,to,PREP,75
77,GAGE1 wt Allele,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>However, expression of       non-mutant GAGE-1, -2 RNA was demonstrated exclusively in 6/10 HCC samples.</br></a><font color='red'>GAGE-1</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",47,106,to,PREP,76
78,MDM2 gene,Focal Nodular Hyperplasia,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Neither GAGE-1, -2 expression nor MDM2       mutations were observed in the FNH samples, or in normal hepatocytes.</br></a><font color='red'>MDM2</font> <font color='blue'>in </font> <font color='green'>FNH</font></p>",45,163,to,PREP,77
79,GAGE1 wt Allele,Focal Nodular Hyperplasia,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10389981' target='_blank'>Neither GAGE-1, -2 expression nor MDM2       mutations were observed in the FNH samples, or in normal hepatocytes.</br></a><font color='red'>GAGE-1</font> <font color='blue'>in </font> <font color='green'>FNH</font></p>",47,163,to,PREP,78
80,HPSE gene,Neoplasm Metastasis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10395325' target='_blank'>This       represents the first cloned mammalian heparanase, to our knowledge, and provides        direct evidence for its role in tumor metastasis.</br></a><font color='red'>heparanase</font> <font color='blue'>role </font> <font color='green'>tumor metastasis</font></p>",50,164,to,NOM,79
81,gene therapy,Liver carcinoma,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10395376' target='_blank'>To improve the efficacy and selectivity of gene therapy for hepatocellular       carcinoma (HCC), we designed a strategy for suicide gene therapy in conjunction       with radiation therapy using an HVJ-liposome vector system.</br></a><font color='red'>gene therapy</font> <font color='blue'>for </font> <font color='green'>hepatocellular       carcinoma</font></p>",51,106,to,PREP,80
82,Immunotherapy,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10397245' target='_blank'>Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.</br></a><font color='red'>immunotherapy</font> <font color='blue'>for </font> <font color='green'>hepatocellular carcinoma</font></p>,52,106,to,PREP,81
83,gene therapy,Disease,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10397245' target='_blank'>This provides a rational, gene therapy-based       strategy for this disease, which is responsible for the largest number of       cancer-related deaths worldwide.</br></a><font color='red'>gene therapy</font> <font color='blue'>for </font> <font color='green'>disease</font></p>",51,165,to,PREP,82
84,CYP1A1 gene,"Hepatitis B, Chronic",ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10408872' target='_blank'>Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma       among chronic hepatitis B carriers.</br></a><font color='red'>Cytochrome P450 1A1 genetic</font> <font color='blue'>carriers.</font> <font color='green'>chronic hepatitis B</font></p>,53,166,to,NOM,83
85,"CYP1A1 protein, human","Hepatitis B, Chronic",ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10408872' target='_blank'>Genotypic variants of CYP1A1 were determined       using polymerase chain reaction in 81 incident cases of HCC and 409 controls       nested in a cohort study of 4841 male chronic HBV carriers.</br></a><font color='red'>CYP1A1</font> <font color='blue'>carriers.</font> <font color='green'>chronic HBV</font></p>,54,166,to,NOM,84
86,TMPRSS13 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10408872' target='_blank'>In the absence of the Ile-Val variant allele, the Mspl       polymorphism was still associated with smoking-related HCC.</br></a><font color='red'>Mspl</font> <font color='blue'>associated </font> <font color='green'>HCC</font></p>",55,106,to,VERB,85
87,FOXD3 gene,Hepatocarcinogenesis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10411141' target='_blank'>An albumin-simian virus 40 (SV40) large T-antigen (T-Ag) transgenic model and a       chemically induced model of multistage hepatocarcinogenesis were created in our       laboratory to study the molecular mechanisms involved in the genesis and       progression of neoplasia in the rat liver.</br></a><font color='red'>genesis</font> <font color='blue'>involved </font> <font color='green'>hepatocarcinogenesis</font></p>,56,1,to,VERB,86
88,Tumor Suppressor Genes,Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10411141' target='_blank'>In the study presented here, these two       models of rat hepatocarcinogenesis were used to perform a comparative mutational        analysis of three tumor suppressor genes involved in hepatic neoplastic growth.</br></a><font color='red'>tumor suppressor genes</font> <font color='blue'>involved </font> <font color='green'>neoplastic growth</font></p>",13,167,to,VERB,87
89,Open Reading Frames,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10411141' target='_blank'>The latter is       homologous to the human M6P/IGF2r coding sequence which is mutated in human       hepatocellular carcinoma.</br></a><font color='red'>coding sequence</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,57,106,to,PREP,88
90,APC gene,Tumorigenicity,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10411141' target='_blank'>A complete single strand conformation polymorphism       analysis of the entire coding region of the rat adenomatous polyposis coli (Apc)        gene was also performed for the first time in rat tumorigenic samples.</br></a><font color='red'>adenomatous polyposis coli</font> <font color='blue'>in </font> <font color='green'>tumorigenic</font></p>,12,168,to,PREP,89
91,Carcinoembryonic Antigen,Secondary malignant neoplasm of liver,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>Involvement of circulating CEA in liver metastases from colorectal cancers       re-examined in a new experimental model.</br></a><font color='red'>CEA</font> <font color='blue'>in </font> <font color='green'>liver metastases</font></p>,58,169,to,PREP,90
92,Carcinoembryonic Antigen,Facilitation,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>For this reason, we       developed a new experimental model to evaluate the possible role of circulating       CEA in the facilitation of liver metastases.</br></a><font color='red'>CEA</font> <font color='blue'>role </font> <font color='green'>facilitation</font></p>",58,170,to,NOM,91
93,"DNA, Complementary",Anabolism,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>A CEA-negative subclone from the       human colon carcinoma cell line CO115 was transfected either with CEA-cDNA       truncated at its 3' end by the deletion of 78 base pairs leading to the synthesis       of a secreted form of CEA or with a full-length CEA-cDNA leading to the synthesis       of the entire CEA molecule linked to the cell surface by a GPI anchor.</br></a><font color='red'>cDNA</font> <font color='blue'>leading </font> <font color='green'>synthesis</font></p>,59,171,to,VERB,92
94,"DNA, Complementary",Anabolism,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>A CEA-negative subclone from the       human colon carcinoma cell line CO115 was transfected either with CEA-cDNA       truncated at its 3' end by the deletion of 78 base pairs leading to the synthesis       of a secreted form of CEA or with a full-length CEA-cDNA leading to the synthesis       of the entire CEA molecule linked to the cell surface by a GPI anchor.</br></a><font color='red'>cDNA</font> <font color='blue'>leading </font> <font color='green'>synthesis</font></p>,59,171,to,VERB,93
95,"DNA, Complementary",Anabolism,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>A CEA-negative subclone from the       human colon carcinoma cell line CO115 was transfected either with CEA-cDNA       truncated at its 3' end by the deletion of 78 base pairs leading to the synthesis       of a secreted form of CEA or with a full-length CEA-cDNA leading to the synthesis       of the entire CEA molecule linked to the cell surface by a GPI anchor.</br></a><font color='red'>cDNA</font> <font color='blue'>leading </font> <font color='green'>synthesis</font></p>,59,171,to,VERB,94
96,"DNA, Complementary",Anabolism,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10424738' target='_blank'>A CEA-negative subclone from the       human colon carcinoma cell line CO115 was transfected either with CEA-cDNA       truncated at its 3' end by the deletion of 78 base pairs leading to the synthesis       of a secreted form of CEA or with a full-length CEA-cDNA leading to the synthesis       of the entire CEA molecule linked to the cell surface by a GPI anchor.</br></a><font color='red'>cDNA</font> <font color='blue'>leading </font> <font color='green'>synthesis</font></p>,59,171,to,VERB,95
97,TSG101 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10448275' target='_blank'>Analysis of aberrant transcription of TSG101 in hepatocellular carcinomas.</br></a><font color='red'>TSG101</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>,60,106,to,PREP,96
98,TSG101 gene,Hepatocarcinogenesis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10448275' target='_blank'>Our results suggest either that the TSG101       gene may not be involved in hepatocarcinogenesis or that it plays a role in the       development and/or progress of hepatocellular carcinomas through an unusual       mechanism.</br></a><font color='red'>TSG101       gene</font> <font color='blue'>involved </font> <font color='green'>hepatocarcinogenesis</font></p>,60,1,to,VERB,97
99,Osteonectin,"Fibrosis, Liver",ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10451487' target='_blank'>ON expression by myofibroblasts has been reported in fibrotic human        liver.</br></a><font color='red'>ON</font> <font color='blue'>in </font> <font color='green'>fibrotic human        liver</font></p>,61,172,to,PREP,98
100,Osteonectin,Fibrous bands,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10451487' target='_blank'>Large amounts of ON mRNA and protein were detected in the tumour       capsule, in the fibrous bands, and along capillaries within HCCs.</br></a><font color='red'>ON</font> <font color='blue'>in </font> <font color='green'>fibrous bands</font></p>",61,173,to,PREP,99
101,Proteins,Fibrous bands,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10451487' target='_blank'>Large amounts of ON mRNA and protein were detected in the tumour       capsule, in the fibrous bands, and along capillaries within HCCs.</br></a><font color='red'>protein</font> <font color='blue'>in </font> <font color='green'>fibrous bands</font></p>",62,173,to,PREP,100
102,SPARC gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10451487' target='_blank'>In HCC, ON protein was always detectable, with strong staining in        high-grade tumours, whereas it was mostly undetectable in non-tumour tissues.</br></a><font color='red'>ON</font> <font color='blue'>HCC, ON protein was always detectable, with strong staining in        high-grade tumours,</font> <font color='green'>HCC</font></p>",63,106,to,INFER,101
103,SPARC gene,Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10451487' target='_blank'>In HCC, ON protein was always detectable, with strong staining in        high-grade tumours, whereas it was mostly undetectable in non-tumour tissues.</br></a><font color='red'>ON</font> <font color='blue'>in </font> <font color='green'>tumours</font></p>",63,167,to,PREP,102
104,Ethanol Ablation Therapy,Patients,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10453948' target='_blank'>All patients were       treated with percutaneous ethanol injection therapy and/or transarterial       embolization during follow-up.</br></a><font color='red'>percutaneous ethanol injection</font> <font color='blue'>percutaneous ethanol injection therapy </font> <font color='green'>patients</font></p>,64,174,to,INFER,103
105,Therapeutic procedure,Patients,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10453948' target='_blank'>All patients were       treated with percutaneous ethanol injection therapy and/or transarterial       embolization during follow-up.</br></a><font color='red'>therapy</font> <font color='blue'>treated </font> <font color='green'>patients</font></p>,65,174,to,VERB,104
106,Therapeutic procedure,Patients,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10453948' target='_blank'>Cumulative metastasis-free survival and overall survival were       significantly better in the 24 patients whose AFP mRNA became negative after       treatment than in the 30 patients with persistently positive AFP mRNA (p= 0.0001        and p<0.0001, respectively).</br></a><font color='red'>treatment</font> <font color='blue'>in </font> <font color='green'>patients</font></p>",65,174,to,PREP,105
107,Epidermal Growth Factor Receptor,Chronic liver disease,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>Transforming growth factor-alpha and epidermal growth factor receptor in chronic        liver disease and hepatocellular carcinoma.</br></a><font color='red'>epidermal growth factor receptor</font> <font color='blue'>in </font> <font color='green'>chronic        liver disease</font></p>,66,175,to,PREP,106
108,Epidermal Growth Factor Receptor,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>Transforming growth factor-alpha and epidermal growth factor receptor in chronic        liver disease and hepatocellular carcinoma.</br></a><font color='red'>epidermal growth factor receptor</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,66,106,to,PREP,107
109,Transforming Growth Factor alpha,Chronic liver disease,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>Transforming growth factor-alpha and epidermal growth factor receptor in chronic        liver disease and hepatocellular carcinoma.</br></a><font color='red'>Transforming growth factor-alpha</font> <font color='blue'>in </font> <font color='green'>chronic        liver disease</font></p>,35,175,to,PREP,108
110,Transforming Growth Factor alpha,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>Transforming growth factor-alpha and epidermal growth factor receptor in chronic        liver disease and hepatocellular carcinoma.</br></a><font color='red'>Transforming growth factor-alpha</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,35,106,to,PREP,109
111,Transforming Growth Factor alpha,Hepatocarcinogenesis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>In addition, TGF-alpha has been reported to       play a pivotal role in hepatocarcinogenesis.</br></a><font color='red'>TGF-alpha</font> <font color='blue'>play a pivotal role </font> <font color='green'>hepatocarcinogenesis</font></p>",35,1,to,COMPLEX,110
112,Transforming Growth Factor alpha,Chronic liver disease,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>To evaluate the significance of       TGF-alpha in chronic liver diseases and hepatocellular carcinoma, we examined       serum TGF-alpha, and expression of TGF-alpha, epidermal growth factor receptor       (EGFR) and proliferating cell nuclear antigen (PCNA) mRNA in liver tissues.</br></a><font color='red'>TGF-alpha</font> <font color='blue'>in </font> <font color='green'>chronic liver diseases</font></p>",35,175,to,PREP,111
113,Transforming Growth Factor alpha,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>To evaluate the significance of       TGF-alpha in chronic liver diseases and hepatocellular carcinoma, we examined       serum TGF-alpha, and expression of TGF-alpha, epidermal growth factor receptor       (EGFR) and proliferating cell nuclear antigen (PCNA) mRNA in liver tissues.</br></a><font color='red'>TGF-alpha</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>",35,106,to,PREP,112
114,Transforming Growth Factor alpha,Liver Cirrhosis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10459631' target='_blank'>Serum TGF-alpha level in LC was higher than in other diseases (p<0.01, compared       to CH, HCC and C, respectively).</br></a><font color='red'>TGF-alpha</font> <font color='blue'>in </font> <font color='green'>LC</font></p>",35,176,to,PREP,113
115,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10461064' target='_blank'>Amplification of c-myc in hepatocellular carcinoma: correlation with       clinicopathologic features, proliferative activity and p53 overexpression.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>",4,106,to,PREP,114
116,MYC gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10461064' target='_blank'>Amplification of c-myc in hepatocellular carcinoma: correlation with       clinicopathologic features, proliferative activity and p53 overexpression.</br></a><font color='red'>c-myc</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>",67,106,to,PREP,115
117,Proto-Oncogene Proteins c-myc,Liver Regeneration,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10461064' target='_blank'>Expression of the proto-oncogene c-myc has been implicated in liver regeneration        and hepatocarcinogenesis.</br></a><font color='red'>proto-oncogene c-myc</font> <font color='blue'>implicated </font> <font color='green'>liver regeneration</font></p>,68,177,to,VERB,116
118,"RNA, Messenger",Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10463774' target='_blank'>The reverse transcription-polymerase chain reaction was used to compare the       expression of the secreted form of IL-1ra (sIL-1ra) and the intracellular form of       IL-1ra (icIL-1ra) mRNA in tumor and corresponding benign tissue obtained from 38        patients with gastric carcinoma.</br></a><font color='red'>mRNA</font> <font color='blue'>in </font> <font color='green'>tumor</font></p>,5,167,to,PREP,117
119,"IL1RN protein, human",Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10463774' target='_blank'>On the contrary, icIL-1ra mRNA was detected in all tumors and benign       tissues.</br></a><font color='red'>icIL-1ra</font> <font color='blue'>in </font> <font color='green'>tumors</font></p>",69,167,to,PREP,118
120,TP53 gene,Malignant Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10470182' target='_blank'>UNLABELLED: Mutations in the p53 gene are the most frequently reported somatic       gene alteration in human cancer.</br></a><font color='red'>p53 gene</font> <font color='blue'>in </font> <font color='green'>cancer</font></p>,4,81,to,PREP,119
121,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10470182' target='_blank'>CONCLUSION: p53 and c-erb B2 seem to be valuable prognostic factors in HCC.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>,4,106,to,PREP,120
122,"AFP protein, human",Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10476206' target='_blank'>Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy       targeting for hepatocellular carcinoma.</br></a><font color='red'>human alpha-fetoprotein</font> <font color='blue'>for </font> <font color='green'>hepatocellular carcinoma</font></p>,70,106,to,PREP,121
123,Ganciclovir,cell growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10476206' target='_blank'>Consistent with this, LNAFM0.3TK infection could sensitize huH-1/cl.2       cells, as well as HuH-7 and PLC/PRF/5 cells to GCV, but did not affect cell       growth of nonhepatoma cells (HeLa).</br></a><font color='red'>GCV</font> <font color='blue'>affect </font> <font color='green'>cell       growth</font></p>",71,151,to,VERB,122
124,Hypoxia-Inducible Factor 1,energy homeostasis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10477681' target='_blank'>The rate of transcription of several genes encoding proteins involved in O(2) and       energy homeostasis is controlled by hypoxia-inducible factor-1 (HIF-1), a       heterodimeric DNA binding complex composed of alpha and beta subunits.</br></a><font color='red'>hypoxia-inducible factor-1</font> <font color='blue'>controlled </font> <font color='green'>energy homeostasis</font></p>",72,178,to,VERB,123
125,SMAD4 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10490821' target='_blank'>Smad2 and Smad4 gene mutations in hepatocellular carcinoma.</br></a><font color='red'>Smad4</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,29,106,to,PREP,124
126,SMAD2 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10490821' target='_blank'>Smad2 and Smad4 gene mutations in hepatocellular carcinoma.</br></a><font color='red'>Smad2</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,30,106,to,PREP,125
127,Transforming Growth Factor beta,Growth,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10490821' target='_blank'>TGF-beta is a negative regulator of liver growth.</br></a><font color='red'>TGF-beta</font> <font color='blue'>regulator </font> <font color='green'>growth</font></p>,73,138,to,NOM,126
128,Candidate Tumor Suppressor Gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10490821' target='_blank'>Smad family of genes, as       mediators of TGF-beta pathway, are candidate tumor suppressor genes in       hepatocellular carcinoma (HCC).</br></a><font color='red'>candidate tumor suppressor genes</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>",2,106,to,PREP,127
129,Transforming Growth Factor beta,Liver carcinoma,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10490821' target='_blank'>These observation demonstrate        that TGF-beta pathway is altered in hepatocellular carcinoma.</br></a><font color='red'>TGF-beta</font> <font color='blue'>altered </font> <font color='green'>hepatocellular carcinoma</font></p>,73,106,to,VERB,128
130,Liver neoplasms,tumor growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10496524' target='_blank'>The       observed altered gene expression may be related to biological phenotypes of       hepatic tumors, and IL-1ra in particular may positively influence tumor cell       growth through its antagonism of IL-1.</br></a><font color='red'>hepatic tumors</font> <font color='blue'>influence </font> <font color='green'>tumor cell       growth</font></p>",74,179,to,VERB,129
131,Stimulation procedure,Cell Survival,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10498643' target='_blank'>In HepG2 cells, CD40 stimulation does not affect cell viability, but       significantly inhibited Fas and TNFR-mediated apoptosis in a dose-dependent       manner by blocking the activation of CPP32.</br></a><font color='red'>stimulation</font> <font color='blue'>affect </font> <font color='green'>cell viability</font></p>",75,180,to,VERB,130
132,Stimulation procedure,Apoptosis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10498643' target='_blank'>In HepG2 cells, CD40 stimulation does not affect cell viability, but       significantly inhibited Fas and TNFR-mediated apoptosis in a dose-dependent       manner by blocking the activation of CPP32.</br></a><font color='red'>stimulation</font> <font color='blue'>affect </font> <font color='green'>apoptosis</font></p>",75,150,to,VERB,131
133,Heparan Sulfate Proteoglycans,Cell Communication,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10507762' target='_blank'>PR-39 is an endogenous proline-rich antimicrobial peptide which induces the       synthesis of syndecan-1, a transmembrane heparan sulphate proteoglycan involved       in cell-to-matrix interactions and wound healing.</br></a><font color='red'>heparan sulphate proteoglycan</font> <font color='blue'>involved </font> <font color='green'>cell-to-matrix interactions</font></p>",76,181,to,VERB,132
134,Heparan Sulfate Proteoglycans,Wound Healing,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10507762' target='_blank'>PR-39 is an endogenous proline-rich antimicrobial peptide which induces the       synthesis of syndecan-1, a transmembrane heparan sulphate proteoglycan involved       in cell-to-matrix interactions and wound healing.</br></a><font color='red'>heparan sulphate proteoglycan</font> <font color='blue'>involved </font> <font color='green'>wound healing</font></p>",76,182,to,VERB,133
135,Actins,Motile,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10507762' target='_blank'>In contrast, five transfectants with       syndecan-1 gene in the HLF cells revealed suppression of invasive activity but       did not alter the motile activity and actin structures of the cell.</br></a><font color='red'>actin</font> <font color='blue'>alter </font> <font color='green'>motile</font></p>",77,183,to,VERB,134
136,SDC1 gene,Motile,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10507762' target='_blank'>In contrast, five transfectants with       syndecan-1 gene in the HLF cells revealed suppression of invasive activity but       did not alter the motile activity and actin structures of the cell.</br></a><font color='red'>syndecan-1 gene</font> <font color='blue'>alter </font> <font color='green'>motile</font></p>",78,183,to,VERB,135
137,Asialoglycoprotein Receptor,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10507763' target='_blank'>The asialoglycoprotein receptor in human hepatocellular carcinomas: its       expression on proliferating cells.</br></a><font color='red'>asialoglycoprotein receptor</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>,79,106,to,PREP,136
138,PRDM2 gene,Liver neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10508492' target='_blank'>Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma       tumorigenicity by RIZ1.</br></a><font color='red'>RIZ2</font> <font color='blue'>in </font> <font color='green'>hepatoma</font></p>,80,74,to,PREP,137
139,Malignant Neoplasms,Family,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10508492' target='_blank'>An unusual feature of this family is the yin-yang involvement in human cancers.</br></a><font color='red'>cancers</font> <font color='blue'>involvement </font> <font color='green'>family</font></p>,81,184,to,NOM,138
140,PRDM2 gene,Liver neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10508492' target='_blank'>Here, we have investigated the role of RIZ in hepatoma.</br></a><font color='red'>RIZ</font> <font color='blue'>role </font> <font color='green'>hepatoma</font></p>",80,74,to,NOM,139
141,Proteins,Malignant Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10508492' target='_blank'>Our observations reinforce the yin-yang notion of RIZ gene       products in human cancer and suggest a RIZ1 tumor suppressor role in hepatoma.</br></a><font color='red'>gene       products</font> <font color='blue'>in </font> <font color='green'>cancer</font></p>,62,81,to,PREP,140
142,Tumor Suppressor Genes,Liver neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10508492' target='_blank'>Our observations reinforce the yin-yang notion of RIZ gene       products in human cancer and suggest a RIZ1 tumor suppressor role in hepatoma.</br></a><font color='red'>tumor suppressor</font> <font color='blue'>role </font> <font color='green'>hepatoma</font></p>,13,74,to,NOM,141
143,Genes,Carcinogenesis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10519413' target='_blank'>Identification and characterization of genes associated with human hepatocellular       carcinogenesis.</br></a><font color='red'>genes</font> <font color='blue'>associated </font> <font color='green'>carcinogenesis</font></p>,82,153,to,VERB,142
144,Growth Factor,Precancerous Conditions,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10519413' target='_blank'>These transcripts are differentially regulated depending on       cell-cell contact, serum growth factors, growth and differentiation status,       and/or other mechanisms in premalignant and malignant liver cells.</br></a><font color='red'>growth factors</font> <font color='blue'>in </font> <font color='green'>premalignant</font></p>",32,185,to,PREP,143
145,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10523694' target='_blank'>The structural abnormalities of the p53 gene have frequently been detected in       hepatocellular carcinomas (HCCs).</br></a><font color='red'>p53 gene</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>,4,106,to,PREP,144
146,Genes,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10523694' target='_blank'>To ascertain whether or not functional       inactivation of this gene also occurs in HCCs, the transactivation of p53 gene       products in 11 HCC cell lines maintained in our laboratory and 26 HCC surgical       specimens was examined by yeast functional assay (functional analysis of       separated alleles in yeast: FASAY), which determines the functional status of the       individual p53 alleles.</br></a><font color='red'>gene</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",82,106,to,PREP,145
147,Protein p53,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10523694' target='_blank'>These results show that functional inactivation of p53 gene       products often occurs in HCCs and that the inactivation frequency of the gene in        HCCs is well correlated with differentiation degree and tumor size, suggesting       that the inactivation of p53 gene products plays a role in progression from well        to poorly differentiated HCC.</br></a><font color='red'>p53 gene       products</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",83,106,to,PREP,146
148,Genes,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10523694' target='_blank'>These results show that functional inactivation of p53 gene       products often occurs in HCCs and that the inactivation frequency of the gene in        HCCs is well correlated with differentiation degree and tumor size, suggesting       that the inactivation of p53 gene products plays a role in progression from well        to poorly differentiated HCC.</br></a><font color='red'>gene</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",82,106,to,PREP,147
149,Genes,Colorectal Cancer,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10551902' target='_blank'>MATERIALS AND METHODS: The human       ICAM-1 (hICAM1) gene was inserted into an HSV amplicon vector and tested in a       transplantable rat hepatocellular carcinoma and in a human colorectal cancer cell       line.</br></a><font color='red'>gene</font> <font color='blue'>in </font> <font color='green'>colorectal cancer</font></p>,82,186,to,PREP,148
150,Genes,Rat Hepatocellular Carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10551902' target='_blank'>MATERIALS AND METHODS: The human       ICAM-1 (hICAM1) gene was inserted into an HSV amplicon vector and tested in a       transplantable rat hepatocellular carcinoma and in a human colorectal cancer cell       line.</br></a><font color='red'>gene</font> <font color='blue'>in </font> <font color='green'>rat hepatocellular carcinoma</font></p>,82,187,to,PREP,149
151,Therapeutic radiology procedure,tumor growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10551902' target='_blank'>Additionally, immunization       with irradiated (10,000 rads) HSV-hICAM1-transduced tumor cells was performed to        determine its effect on tumor growth.</br></a><font color='red'>irradiated</font> <font color='blue'>effect </font> <font color='green'>tumor growth</font></p>",84,179,to,NOM,150
152,BCL-2 Protein,Chemosensitivity,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567879' target='_blank'>The study examines the       effect of Bcl-2 protein on the chemosensitivity of a human hepatocellular       carcinoma cell line, QGY-7703.</br></a><font color='red'>Bcl-2 protein</font> <font color='blue'>effect </font> <font color='green'>chemosensitivity</font></p>",85,188,to,NOM,151
153,Retinoblastoma Protein,Tumor Progression,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>Over-expression and lack of retinoblastoma protein are associated with tumor       progression and metastasis in hepatocellular carcinoma.</br></a><font color='red'>retinoblastoma protein</font> <font color='blue'>associated </font> <font color='green'>tumor       progression</font></p>,86,189,to,VERB,152
154,Retinoblastoma Protein,Secondary Neoplasm,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>Over-expression and lack of retinoblastoma protein are associated with tumor       progression and metastasis in hepatocellular carcinoma.</br></a><font color='red'>retinoblastoma protein</font> <font color='blue'>associated </font> <font color='green'>metastasis</font></p>,86,156,to,VERB,153
155,"Hepatitis, Chronic",Hepatocarcinogenesis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>To determine the role of retinoblastoma (Rb) gene alteration in       hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in       a series of surgically resected specimens including non-cancerous liver tissues       with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cancerous       adenomatous hyperplasias as well as primary and metastatic lesions of       hepatocellular carcinoma (HCC).</br></a><font color='red'>chronic hepatitis</font> <font color='blue'>role </font> <font color='green'>hepatocarcinogenesis</font></p>",87,1,to,NOM,154
156,Adenomatous hyperplasia,Hepatocarcinogenesis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>To determine the role of retinoblastoma (Rb) gene alteration in       hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in       a series of surgically resected specimens including non-cancerous liver tissues       with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cancerous       adenomatous hyperplasias as well as primary and metastatic lesions of       hepatocellular carcinoma (HCC).</br></a><font color='red'>adenomatous hyperplasias</font> <font color='blue'>role </font> <font color='green'>hepatocarcinogenesis</font></p>",88,1,to,NOM,155
157,Retinoblastoma Protein,Neoplasm Metastasis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>Our observations suggest       that elevated and absent Rb protein are closely associated with tumor progression       and developing metastatic disease rather than tumor initiation in cases of HCC.</br></a><font color='red'>Rb protein</font> <font color='blue'>associated </font> <font color='green'>metastatic disease</font></p>,86,164,to,VERB,156
158,Retinoblastoma Protein,Tumor Progression,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10567906' target='_blank'>Our observations suggest       that elevated and absent Rb protein are closely associated with tumor progression       and developing metastatic disease rather than tumor initiation in cases of HCC.</br></a><font color='red'>Rb protein</font> <font color='blue'>associated </font> <font color='green'>tumor progression</font></p>,86,189,to,VERB,157
159,Gene Mutation,Wild Type,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10569800' target='_blank'>PPARalpha-null mice showed no hepatic APP gene alteration after PP treatment but        had higher basal expression than did wild-type controls.</br></a><font color='red'>gene alteration</font> <font color='blue'>controls.</font> <font color='green'>wild-type</font></p>,89,190,to,NOM,158
160,CDKN2A gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10575317' target='_blank'>CDKN2 mutation is infrequent in german hepatocellular carcinoma.</br></a><font color='red'>CDKN2</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,34,106,to,PREP,159
161,CDKN2A gene,Hepatocarcinogenesis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10575317' target='_blank'>We conclude that the alteration of CDKN2 by deletion or mutation       appears not to be a frequent event in hepatocarcinogenesis in German patients.</br></a><font color='red'>CDKN2</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>,34,1,to,PREP,160
162,Genes,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10576668' target='_blank'>Expression of MAGE-1 and -3 genes and gene products in human hepatocellular       carcinoma.</br></a><font color='red'>genes</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinoma</font></p>,82,106,to,PREP,161
163,Proteins,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10576668' target='_blank'>Expression of MAGE-1 and -3 genes and gene products in human hepatocellular       carcinoma.</br></a><font color='red'>gene products</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinoma</font></p>,62,106,to,PREP,162
164,Detection,Early Hepatocellular Carcinoma,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10576668' target='_blank'>Our results indicate that the       detection of the genes by RT-PCR or the proteins by Western blotting is useful       for differentiating early HCCs from non-cancerous lesions, and that the peptides        derived from MAGE-1 and -3 proteins might be suitable targets for immunotherapy       of human HCC.</br></a><font color='red'>detection</font> <font color='blue'>for </font> <font color='green'>early HCCs</font></p>",90,191,to,PREP,163
165,,Liver neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10580126' target='_blank'>The       mechanisms by which alpha1-6 fucosylation of AFP occurs in the hepatoma is not       due to the up-regulation of alpha1-6FucT alone.</br></a><font color='red'>AFP</font> <font color='blue'>in </font> <font color='green'>hepatoma</font></p>,NA,74,to,PREP,164
166,BCL10 gene,Lymphoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10582682' target='_blank'>Point mutations and deletions of the Bcl10 gene in solid tumors and malignant       lymphomas.</br></a><font color='red'>Bcl10 gene</font> <font color='blue'>in </font> <font color='green'>malignant       lymphomas</font></p>,91,192,to,PREP,165
167,BCL10 gene,solid tumor,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10582682' target='_blank'>Point mutations and deletions of the Bcl10 gene in solid tumors and malignant       lymphomas.</br></a><font color='red'>Bcl10 gene</font> <font color='blue'>in </font> <font color='green'>solid tumors</font></p>,91,9,to,PREP,166
168,BCL10 gene,solid tumor,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10582682' target='_blank'>In contrast, we       detected Bcl10 mutations in 4 of 120 lymphomas (3.3%) and 2 of 78 GCTs (2.6%),       respectively, but no mutation was found in the remaining solid tumors analyzed.</br></a><font color='red'>Bcl10</font> <font color='blue'>in </font> <font color='green'>solid tumors</font></p>",91,9,to,PREP,167
169,BCL10 gene,Pathogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10582682' target='_blank'>Taken together, these data imply that Bcl10 may occasionally be involved in the       pathogenesis of lymphoma and GCTs.</br></a><font color='red'>Bcl10</font> <font color='blue'>involved </font> <font color='green'>pathogenesis</font></p>",91,18,to,VERB,168
170,BCL10 gene,Neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10582682' target='_blank'>However, the absence or low frequency of the       mutation suggests that either Bcl10 is inactivated by other mechanisms or it is       not the only target of chromosome 1p22 deletion in human tumors.</br></a><font color='red'>Bcl10</font> <font color='blue'>in </font> <font color='green'>tumors</font></p>",91,167,to,PREP,169
171,apoptosis signaling,Apoptosis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10583438' target='_blank'>CONCLUSIONS: Thus, it is unlikely that hepatitis C       virus core or E2 protein inhibit apoptosis mediated by apoptosis-signalling       pathways sensitive to cytokine response modifier A protein.</br></a><font color='red'>apoptosis-signalling       pathways</font> <font color='blue'>mediated </font> <font color='green'>apoptosis</font></p>",92,150,to,VERB,170
172,"nucleocapsid protein, Hepatitis C virus",Apoptosis,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10583438' target='_blank'>Discrepancies to       previous reports probably reflect specific effects of hepatitis C virus core       protein on different apoptotic pathways and/ or cell lines.</br></a><font color='red'>hepatitis C virus core       protein</font> <font color='blue'>effects </font> <font color='green'>apoptotic pathways</font></p>,93,150,to,NOM,171
173,oncostatin M,Heterodimerization,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10586060' target='_blank'>Leukemia inhibitory factor (LIF), cardiotrophin-1, ciliary neurotrophic factor,       and oncostatin M (OSM) lead to heterodimerization of LIF receptor (LIFR) or the       OSM-specific receptor (OSMR) with glycoprotein (gp) 130, the common receptor       subunit for IL-6-type cytokines.</br></a><font color='red'>oncostatin M</font> <font color='blue'>lead </font> <font color='green'>heterodimerization</font></p>",94,193,to,VERB,172
174,leukemia inhibitory factor,Heterodimerization,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10586060' target='_blank'>Leukemia inhibitory factor (LIF), cardiotrophin-1, ciliary neurotrophic factor,       and oncostatin M (OSM) lead to heterodimerization of LIF receptor (LIFR) or the       OSM-specific receptor (OSMR) with glycoprotein (gp) 130, the common receptor       subunit for IL-6-type cytokines.</br></a><font color='red'>Leukemia inhibitory factor</font> <font color='blue'>lead </font> <font color='green'>heterodimerization</font></p>",95,193,to,VERB,173
175,Ciliary Neurotrophic Factor,Heterodimerization,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10586060' target='_blank'>Leukemia inhibitory factor (LIF), cardiotrophin-1, ciliary neurotrophic factor,       and oncostatin M (OSM) lead to heterodimerization of LIF receptor (LIFR) or the       OSM-specific receptor (OSMR) with glycoprotein (gp) 130, the common receptor       subunit for IL-6-type cytokines.</br></a><font color='red'>ciliary neurotrophic factor</font> <font color='blue'>lead </font> <font color='green'>heterodimerization</font></p>",96,193,to,VERB,174
176,cardiotrophin 1,Heterodimerization,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10586060' target='_blank'>Leukemia inhibitory factor (LIF), cardiotrophin-1, ciliary neurotrophic factor,       and oncostatin M (OSM) lead to heterodimerization of LIF receptor (LIFR) or the       OSM-specific receptor (OSMR) with glycoprotein (gp) 130, the common receptor       subunit for IL-6-type cytokines.</br></a><font color='red'>cardiotrophin-1</font> <font color='blue'>lead </font> <font color='green'>heterodimerization</font></p>",97,193,to,VERB,175
177,"Transcription, Genetic",FHIT gene,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10589760' target='_blank'>To determine whether transcriptional alterations of the fragile histidine triad       (FHIT) gene play a role in the development and progression of human       hepatocellular carcinoma (HCC) we used reverse transcription-PCR to examine mRNA        FHIT expression in 28 paired samples of HCC (24 in cirrhotic and 4 in       noncirrhotic livers) and matched noncancerous tissue and in 10 normal livers.</br></a><font color='red'>transcriptional</font> <font color='blue'>alterations </font> <font color='green'>fragile histidine triad       (FHIT) gene</font></p>,98,46,to,NOM,176
178,Matched Tissues,Liver normal,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10589760' target='_blank'>To determine whether transcriptional alterations of the fragile histidine triad       (FHIT) gene play a role in the development and progression of human       hepatocellular carcinoma (HCC) we used reverse transcription-PCR to examine mRNA        FHIT expression in 28 paired samples of HCC (24 in cirrhotic and 4 in       noncirrhotic livers) and matched noncancerous tissue and in 10 normal livers.</br></a><font color='red'>matched noncancerous tissue</font> <font color='blue'>in </font> <font color='green'>normal livers</font></p>,99,194,to,PREP,177
179,APOBEC1 gene,Carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10597235' target='_blank'>This investigation aimed to define whether such aberrant hyperediting        mediated by APOBEC-1 occurs in human carcinomas.</br></a><font color='red'>APOBEC-1</font> <font color='blue'>in </font> <font color='green'>carcinomas</font></p>,100,195,to,PREP,178
180,apoB mRNA editing catalytic subunit,Carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10597235' target='_blank'>Taken together, either APOBEC-1 or       the 'auxiliary' components of the apo B mRNA editing enzyme-complex or both are       missing in human carcinomas resulting in the absence of mRNA editing.</br></a><font color='red'>APOBEC-1</font> <font color='blue'>in </font> <font color='green'>carcinomas</font></p>",101,195,to,PREP,179
181,Proteins,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10597262' target='_blank'>Close correlation between beta-catenin gene alterations and nuclear accumulation        of the protein in human hepatocellular carcinomas.</br></a><font color='red'>protein</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>,62,106,to,PREP,180
182,CTNNB1 gene,Fibrolamellar hepatocellular carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10597262' target='_blank'>Our results indicate that       accumulation of beta-catenin resulting from genetic mutations is a frequent event       in non-fibrolamellar type hepatocellular carcinoma.</br></a><font color='red'>beta-catenin</font> <font color='blue'>in </font> <font color='green'>fibrolamellar type hepatocellular carcinoma</font></p>,14,196,to,PREP,181
183,trichostatin A,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10601571' target='_blank'>Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in       the treatment of hepatocellular carcinoma.</br></a><font color='red'>trichostatin A</font> <font color='blue'>treatment </font> <font color='green'>hepatocellular carcinoma</font></p>,102,106,to,NOM,182
184,HDAC1 gene,Hepatocarcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10601571' target='_blank'>Mutations and alterations of the       IGF-axis as well as of chromosome 1p34, where the genes for histone deacetylase 1       (HDAC1) and transforming growth factor beta receptor interacting protein-1       (TRIP-1) map, are frequent events in hepatocarcinogenesis.</br></a><font color='red'>histone deacetylase 1</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>",103,1,to,PREP,183
185,Recombinant Transforming Growth Factor-Beta 1,Hepatocarcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10601571' target='_blank'>Mutations and alterations of the       IGF-axis as well as of chromosome 1p34, where the genes for histone deacetylase 1       (HDAC1) and transforming growth factor beta receptor interacting protein-1       (TRIP-1) map, are frequent events in hepatocarcinogenesis.</br></a><font color='red'>transforming growth factor beta receptor interacting protein-1</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>",104,1,to,PREP,184
186,Insulin-Like Growth Factor Binding Protein 3,Liver carcinoma,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10601571' target='_blank'>As IGFBP-3 has been shown to induce apoptosis, these results suggest a possible       use for histone deacetylase inhibitors and/or IGFBP-3 in the treatment of HCC.</br></a><font color='red'>IGFBP-3</font> <font color='blue'>treatment </font> <font color='green'>HCC</font></p>",105,106,to,NOM,185
187,Liver carcinoma,Patients,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10606185' target='_blank'>We       examined the backgrounds of 34 NB and NC (NBNC) Japanese patients with chronic       liver disease (CLD) patients not associated with HCC and 26 NBNC CLD patients       with HCC.</br></a><font color='red'>HCC</font> <font color='blue'>associated </font> <font color='green'>patients</font></p>,106,174,to,VERB,186
188,"PSMD10 protein, human",cell growth,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10613832' target='_blank'>These results       demonstrate the importance of ubiquitin-proteasome pathway in the regulation of       cell growth and oncogenic transformation, and indicate that gankyrin       overexpression contributes to hepatocarcinogenesis by destabilizing RB1.</br></a><font color='red'>gankyrin</font> <font color='blue'>regulation </font> <font color='green'>cell growth</font></p>",107,151,to,NOM,187
189,"PSMD10 protein, human","Transformation, function",AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10613832' target='_blank'>These results       demonstrate the importance of ubiquitin-proteasome pathway in the regulation of       cell growth and oncogenic transformation, and indicate that gankyrin       overexpression contributes to hepatocarcinogenesis by destabilizing RB1.</br></a><font color='red'>gankyrin</font> <font color='blue'>regulation </font> <font color='green'>transformation</font></p>",107,197,to,NOM,188
190,MDK gene,Carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10626184' target='_blank'>BACKGROUND/AIMS: Aberrant expression of Midkine (MK) has been found in various       human carcinomas including hepatocellular carcinoma (HCC).</br></a><font color='red'>Midkine</font> <font color='blue'>in </font> <font color='green'>carcinomas</font></p>,108,195,to,PREP,189
191,Erythropoietin,Renal Cell Carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10628941' target='_blank'>Gene expression of erythropoietin in renal cell carcinoma.</br></a><font color='red'>erythropoietin</font> <font color='blue'>in </font> <font color='green'>renal cell carcinoma</font></p>,109,198,to,PREP,190
192,Base Sequence,Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10628941' target='_blank'>Nucleotide sequences of EPO cDNA in the tumor were normal.</br></a><font color='red'>Nucleotide sequences</font> <font color='blue'>in </font> <font color='green'>tumor</font></p>,110,167,to,PREP,191
193,PTGS2 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10632332' target='_blank'>Recent studies have shown increased levels of cyclooxygenase-2 (COX-2) in a       variety of human malignancies including hepatocellular carcinoma (HCC), but       little is known about the prognostic value of COX-2 in HCC or its associated       nontumor liver tissue.</br></a><font color='red'>COX-2</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",111,106,to,PREP,192
194,HFE gene,Iron Overload,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10660482' target='_blank'>In hereditary hemochromatosis an       increased frequency of the C282Y and, to a lesser extent, of the H63D mutations       has been established, but their role in other conditions associated with iron       overload and their prevalence in the normal population are still under       investigation.</br></a><font color='red'>hereditary hemochromatosis</font> <font color='blue'>associated </font> <font color='green'>iron       overload</font></p>",112,199,to,VERB,193
195,Neoplastic Cell Transformation,Mutation,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10660482' target='_blank'>We sought to determine the presence of such mutations, and their       possible involvement in the multi-step neoplastic transformation of the       hepatocytes, in patients diagnosed with hepatocellular carcinoma, a frequent       complication of iron-induced liver cirrhosis occurring in untreated hereditary       hemochromatosis subjects.</br></a><font color='red'>neoplastic transformation</font> <font color='blue'>involvement </font> <font color='green'>mutations</font></p>",113,200,to,NOM,194
196,Liver carcinoma,Pathogenesis,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10660482' target='_blank'>In conclusion, we suggest that the hereditary       hemochromatosis-related mutations of the HFE gene do not play a significant role        in the pathogenesis of hepatocellular carcinoma.</br></a><font color='red'>hepatocellular carcinoma</font> <font color='blue'>play a significant role </font> <font color='green'>pathogenesis</font></p>",106,18,to,COMPLEX,195
197,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10662591' target='_blank'>Microsatellite instability and p53 mutations in hepatocellular carcinoma.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,4,106,to,PREP,196
198,TP53 gene,Microsatellite Instability,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10662591' target='_blank'>We have studied 27 hepatocellular carcinomas (HCCs) to identify possible       relationships between microsatellite instability (MSI), p53 mutations, and HBV       infection in hepatocarcinogenesis.</br></a><font color='red'>p53</font> <font color='blue'>relationships </font> <font color='green'>microsatellite instability</font></p>",4,114,to,NOM,197
199,Microsatellite Instability,TP53 gene,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10662591' target='_blank'>Only 1/5 samples with MSI in more than two markers harbored a mutation in p53.</br></a><font color='red'>MSI</font> <font color='blue'>in </font> <font color='green'>p53</font></p>,114,4,to,PREP,198
200,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10662591' target='_blank'>Although the number of samples is too small to support a statistical       significance, this finding may indicate an inverse relationship between p53       mutations and MSI in HCC.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",4,106,to,PREP,199
201,CTNNB1 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10665646' target='_blank'>Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in       hepatocellular carcinoma.</br></a><font color='red'>beta-catenin gene</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,14,106,to,PREP,200
202,Anaplastic Oligodendroglioma,Mutation,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10665646' target='_blank'>The present results indicate that (1) mutation of       exon 3 of the beta-catenin gene can lead to beta-catenin accumulation, although       other mechanisms of accumulation may also operate in HCC, and (2) beta-catenin       accumulation and mutation of the beta-catenin gene are not early events in       hepatocarcinogenesis, and may be associated with the malignant progression of       HCC.</br></a><font color='red'>malignant</font> <font color='blue'>associated </font> <font color='green'>mutation</font></p>",115,200,to,VERB,201
203,Anaplastic Oligodendroglioma,Mutation,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10665646' target='_blank'>The present results indicate that (1) mutation of       exon 3 of the beta-catenin gene can lead to beta-catenin accumulation, although       other mechanisms of accumulation may also operate in HCC, and (2) beta-catenin       accumulation and mutation of the beta-catenin gene are not early events in       hepatocarcinogenesis, and may be associated with the malignant progression of       HCC.</br></a><font color='red'>malignant</font> <font color='blue'>associated </font> <font color='green'>mutation</font></p>",115,200,to,VERB,202
204,CTNNB1 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10665646' target='_blank'>The present results indicate that (1) mutation of       exon 3 of the beta-catenin gene can lead to beta-catenin accumulation, although       other mechanisms of accumulation may also operate in HCC, and (2) beta-catenin       accumulation and mutation of the beta-catenin gene are not early events in       hepatocarcinogenesis, and may be associated with the malignant progression of       HCC.</br></a><font color='red'>beta-catenin gene</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",14,106,to,PREP,203
205,CTNNB1 gene,Hepatocarcinogenesis,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10665646' target='_blank'>The present results indicate that (1) mutation of       exon 3 of the beta-catenin gene can lead to beta-catenin accumulation, although       other mechanisms of accumulation may also operate in HCC, and (2) beta-catenin       accumulation and mutation of the beta-catenin gene are not early events in       hepatocarcinogenesis, and may be associated with the malignant progression of       HCC.</br></a><font color='red'>beta-catenin gene</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>",14,1,to,PREP,204
206,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10671685' target='_blank'>Correlation of immunohistochemical staining and mutations of p53 in human       hepatocellular carcinoma.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinoma</font></p>,4,106,to,PREP,205
207,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10671685' target='_blank'>Mutations of the p53 tumor suppressor gene are common in hepatocellular       carcinomas (HCCs).</br></a><font color='red'>p53 tumor suppressor gene</font> <font color='blue'>in </font> <font color='green'>hepatocellular       carcinomas</font></p>,4,106,to,PREP,206
208,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10671685' target='_blank'>In addition,       exons 5-8 of the p53 gene were sequenced in these HCCs.</br></a><font color='red'>p53 gene</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",4,106,to,PREP,207
209,TP53 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10671685' target='_blank'>Immunohistochemical staining to detect p53 mutations in human       HCCs detected most mutations that were detected by sequencing (94% sensitivity,       73% specificity), and this method is therefore suitable when sequencing cannot be       performed.</br></a><font color='red'>p53</font> <font color='blue'>in </font> <font color='green'>HCCs</font></p>",4,106,to,PREP,208
210,,Cells,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10673071' target='_blank'>In this series of experiments, in addition to AFP mRNA       inhibition being as extensive and more prolonged (maximum duration: 6-12 h) in       muscimol-treated, GABA(A) receptor-transfected cells, proliferative activity was        also significantly inhibited when compared to saline-treated GABA(A)       receptor-transfected controls (p<0.01) and muscimol-treated cells transfected       with vector alone (p<0.005).</br></a><font color='red'>AFP</font> <font color='blue'>prolonged </font> <font color='green'>cells</font></p>",NA,201,to,VERB,209
211,,Receptor Cell,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10673071' target='_blank'>In this series of experiments, in addition to AFP mRNA       inhibition being as extensive and more prolonged (maximum duration: 6-12 h) in       muscimol-treated, GABA(A) receptor-transfected cells, proliferative activity was        also significantly inhibited when compared to saline-treated GABA(A)       receptor-transfected controls (p<0.01) and muscimol-treated cells transfected       with vector alone (p<0.005).</br></a><font color='red'>AFP</font> <font color='blue'>prolonged </font> <font color='green'>receptor-transfected cells</font></p>",NA,202,to,VERB,210
212,"Genes, Suppressor",Malignant tumor of colon,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10676663' target='_blank'>Drg-1 as a differentiation-related, putative metastatic suppressor gene in human        colon cancer.</br></a><font color='red'>suppressor gene</font> <font color='blue'>in </font> <font color='green'>colon cancer</font></p>",116,139,to,PREP,211
213,NF-kappa B,Apoptosis,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in       adenoviral hepatitis.</br></a><font color='red'>NFkappaB</font> <font color='blue'>mediates </font> <font color='green'>apoptosis</font></p>,117,150,to,VERB,212
214,,adenovirus hepatitis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in       adenoviral hepatitis.</br></a><font color='red'>Fas</font> <font color='blue'>in </font> <font color='green'>adenoviral hepatitis</font></p>,NA,118,to,PREP,213
215,adenovirus hepatitis,Mouse Model,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>We have assessed the role of NFkB during the early       phase of adenoviral hepatitis in a nude mouse model using an adenoviral vector       expressing a mutant form of IkappaBalpha.</br></a><font color='red'>adenoviral hepatitis</font> <font color='blue'>role </font> <font color='green'>mouse model</font></p>,118,203,to,NOM,214
216,Adenoviral infections,caspase-3 activity,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>Compared with the control,       IkappaBalpha adenoviral infection resulted in reduced caspase 3 activity during       the early phase of viral hepatitis and in a prevention of liver cell apoptosis 24       h after adenoviral administration.</br></a><font color='red'>adenoviral infection</font> <font color='blue'>in </font> <font color='green'>caspase 3 activity</font></p>",119,204,to,PREP,215
217,pro-apoptosis,Hepatocyte,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>Therefore our study demonstrates a new       pro-apoptotic function of NFkappaB in Fas (CD95)-mediated apoptosis of       hepatocytes.</br></a><font color='red'>pro-apoptotic</font> <font color='blue'>mediated </font> <font color='green'>hepatocytes</font></p>,120,205,to,ADJ,216
218,NF-kappa B,hepatocyte apoptotic process,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692445' target='_blank'>Interestingly, NFkappaB mediates liver cell apoptosis upon viral       infection even in a phase where tumor necrosis factor-alpha is already induced,       as shown by the time curves of tumor necrosis factor-alpha serum levels.</br></a><font color='red'>NFkappaB</font> <font color='blue'>mediates </font> <font color='green'>liver cell apoptosis</font></p>",117,206,to,VERB,217
219,CDH1 gene,diffuse carcinoma of the stomach,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692769' target='_blank'>Mutations of the E-cadherin gene, including       germline mutations, occur in diffuse gastric carcinoma, CpG methylation around       the promotor region of E-cadherin in hepatocellular carcinomas and mutations of       the APC tumour suppressor gene or in the beta-catenin oncogene in most colorectal       cancers.</br></a><font color='red'>E-cadherin</font> <font color='blue'>in </font> <font color='green'>diffuse gastric carcinoma</font></p>",121,207,to,PREP,218
220,CDH1 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692769' target='_blank'>Mutations of the E-cadherin gene, including       germline mutations, occur in diffuse gastric carcinoma, CpG methylation around       the promotor region of E-cadherin in hepatocellular carcinomas and mutations of       the APC tumour suppressor gene or in the beta-catenin oncogene in most colorectal       cancers.</br></a><font color='red'>E-cadherin</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>",121,106,to,PREP,219
221,Tumor Suppressor Genes,Colorectal Cancer,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692769' target='_blank'>Mutations of the E-cadherin gene, including       germline mutations, occur in diffuse gastric carcinoma, CpG methylation around       the promotor region of E-cadherin in hepatocellular carcinomas and mutations of       the APC tumour suppressor gene or in the beta-catenin oncogene in most colorectal       cancers.</br></a><font color='red'>tumour suppressor gene</font> <font color='blue'>in </font> <font color='green'>colorectal       cancers</font></p>",13,186,to,PREP,220
222,CTNNB1 gene,Colorectal Cancer,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692769' target='_blank'>Mutations of the E-cadherin gene, including       germline mutations, occur in diffuse gastric carcinoma, CpG methylation around       the promotor region of E-cadherin in hepatocellular carcinomas and mutations of       the APC tumour suppressor gene or in the beta-catenin oncogene in most colorectal       cancers.</br></a><font color='red'>beta-catenin</font> <font color='blue'>in </font> <font color='green'>colorectal       cancers</font></p>",14,186,to,PREP,221
223,CDH1 gene,Malignant neoplasm of gastrointestinal tract,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10692769' target='_blank'>The literature agrees about the disturbance of immunohistochemical       patterns of E-cadherin and catenin expression in gastrointestinal cancers.</br></a><font color='red'>E-cadherin</font> <font color='blue'>in </font> <font color='green'>gastrointestinal cancers</font></p>,121,208,to,PREP,222
224,DNA,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10699924' target='_blank'>In this study, HBV DNA was       isolated from an integration site in one HCC that had a single, very small       integrated viral DNA including the X region, but it had no expression of X gene       as poly(A)RNA.</br></a><font color='red'>DNA</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>",122,106,to,PREP,223
225,AXIN1 gene,Growth retardation,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10700176' target='_blank'>AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer       cells by virus-mediated transfer of AXIN1.</br></a><font color='red'>AXIN1</font> <font color='blue'>in </font> <font color='green'>growth suppression</font></p>",123,209,to,PREP,224
226,AXIN1 gene,Liver carcinoma,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10700176' target='_blank'>AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer       cells by virus-mediated transfer of AXIN1.</br></a><font color='red'>AXIN1</font> <font color='blue'>in </font> <font color='green'>hepatocellular carcinomas</font></p>",123,106,to,PREP,225
227,CTNNB1 gene,Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10700176' target='_blank'>Mutations in CTNNB1 (encoding beta-catenin) or       APC (adenomatous polyposis coli) have been reported in human neoplasms including        colon cancers and hepatocellular carcinomas (HCCs).</br></a><font color='red'>beta-catenin</font> <font color='blue'>in </font> <font color='green'>neoplasms</font></p>,14,167,to,PREP,226
228,PROC wt Allele,Neoplasms,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10700176' target='_blank'>Mutations in CTNNB1 (encoding beta-catenin) or       APC (adenomatous polyposis coli) have been reported in human neoplasms including        colon cancers and hepatocellular carcinomas (HCCs).</br></a><font color='red'>APC</font> <font color='blue'>in </font> <font color='green'>neoplasms</font></p>,21,167,to,PREP,227
229,CDKN2A gene,rodent cell line,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10704681' target='_blank'>Alterations of P19ARF in rodent hepatoma cell lines but not in human primary       liver cancer.</br></a><font color='red'>P19ARF</font> <font color='blue'>Alterations </font> <font color='green'>rodent hepatoma cell lines</font></p>,34,210,to,NOM,228
230,CDKN2A gene,Hepatocarcinogenesis,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10704681' target='_blank'>These results suggest that functional abrogation of       P19ARF is not a primary event in hepatocarcinogenesis.</br></a><font color='red'>P19ARF</font> <font color='blue'>in </font> <font color='green'>hepatocarcinogenesis</font></p>,34,1,to,PREP,229
231,10q,Liver neoplasms,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10705874' target='_blank'>To determine       whether the PTEN/MMAC1 gene is a target of 10q loss of heterozygosity in       hepatoma, we examined 42 primary hepatomas for mutations in PTEN/MMAC1 by using       nested reverse transcriptase polymerase chain reaction (RT-PCR) of the RNA and       single-stranded conformation polymorphism (SSCP) analysis of all genomic exons.</br></a><font color='red'>10q</font> <font color='blue'>in </font> <font color='green'>hepatoma</font></p>",124,74,to,PREP,230
232,PTEN gene,Malignant Neoplasms,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10705874' target='_blank'>Therefore, like the TSG101        or FHIT gene, aberrant transcripts of PTEN/MMAC1 using the nested RT-PCR method       were a common phenomenon for both cancerous and noncancerous liver tissues, which       may not be related to oncogenesis.</br></a><font color='red'>MMAC1</font> <font color='blue'>for </font> <font color='green'>cancerous</font></p>",125,81,to,PREP,231
233,FHIT gene,Neoplastic Cell Transformation,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10705874' target='_blank'>Therefore, like the TSG101        or FHIT gene, aberrant transcripts of PTEN/MMAC1 using the nested RT-PCR method       were a common phenomenon for both cancerous and noncancerous liver tissues, which       may not be related to oncogenesis.</br></a><font color='red'>FHIT gene</font> <font color='blue'>related </font> <font color='green'>oncogenesis</font></p>",46,113,to,VERB,232
234,TSG101 gene,Neoplastic Cell Transformation,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10705874' target='_blank'>Therefore, like the TSG101        or FHIT gene, aberrant transcripts of PTEN/MMAC1 using the nested RT-PCR method       were a common phenomenon for both cancerous and noncancerous liver tissues, which       may not be related to oncogenesis.</br></a><font color='red'>TSG101</font> <font color='blue'>related </font> <font color='green'>oncogenesis</font></p>",60,113,to,VERB,233
235,Liver neoplasms,Pathogenesis,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10705874' target='_blank'>Our results suggest that the PTEN/MMAC1 gene may        not play a role in the pathogenesis of hepatoma.</br></a><font color='red'>hepatoma</font> <font color='blue'>play a role </font> <font color='green'>pathogenesis</font></p>,74,18,to,COMPLEX,234
236,FHIT gene,Liver carcinoma,AFFECTS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10706123' target='_blank'>Alterations of the FHIT gene in human hepatocellular carcinoma.</br></a><font color='red'>FHIT gene</font> <font color='blue'>Alterations </font> <font color='green'>hepatocellular carcinoma</font></p>,46,106,to,NOM,235
237,Genes,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10706550' target='_blank'>Expression of viral or bacterial enzymes in tumor cells to convert nontoxic       prodrugs into highly toxic metabolites is an attractive gene-therapeutic approach       for the treatment of hepatocellular carcinoma (HCC).</br></a><font color='red'>gene</font> <font color='blue'>treatment </font> <font color='green'>hepatocellular carcinoma</font></p>,82,106,to,NOM,236
238,,Neoplasms,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10706550' target='_blank'>Adenoviral delivery of       PNP followed by fludarabine administration prevented subcutaneous and       intrahepatic tumor formation in nude mice and was also effective for the       treatment of established tumors.</br></a><font color='red'>PNP</font> <font color='blue'>treatment </font> <font color='green'>tumors</font></p>,NA,167,to,NOM,237
239,fludarabine,Liver carcinoma,TREATS,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10706550' target='_blank'>These results demonstrate the potential of the       PNP/fludarabine system for the treatment of HCC.</br></a><font color='red'>fludarabine</font> <font color='blue'>treatment </font> <font color='green'>HCC</font></p>,126,106,to,NOM,238
240,DNA Methylation,GSTP1 gene,AFFECTS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10717233' target='_blank'>We report here that the pathogenesis of hepatocellular carcinoma       (HCC), one of the most common cancers in the world, frequently involves an       accumulation of somatic <CpG island> DNA methylation changes at GSTP1, the gene       encoding the pi-class glutathione S-transferase.</br></a><font color='red'>DNA methylation</font> <font color='blue'>changes </font> <font color='green'>GSTP1</font></p>",127,211,to,VERB,239
241,CpG Islands,Liver carcinoma,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10717233' target='_blank'>The data indicate that GSTP1 <CpG island> DNA hypermethylation       changes appear frequently in human HCC.</br></a><font color='red'>CpG island</font> <font color='blue'>in </font> <font color='green'>HCC</font></p>,128,106,to,PREP,240
242,NME1 gene,Colorectal Cancer,ASSOCIATED_WITH,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10719723' target='_blank'>Genomic alterations at the long arm of chromosome 17, and in particular at the       nm23 locus, are still controversial in colorectal cancer (CRC).</br></a><font color='red'>nm23</font> <font color='blue'>in </font> <font color='green'>colorectal cancer</font></p>",129,186,to,PREP,241
243,ASPH gene,Disease,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10728685' target='_blank'>We found that HAAH gene expression was       undetectable during bile duct proliferation in both human disease and rat models        as compared with cholangiocarcinoma.</br></a><font color='red'>HAAH</font> <font color='blue'>in </font> <font color='green'>disease</font></p>,130,165,to,PREP,242
244,Enzymes,metaplastic cell transformation,TREATS,"<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10728685' target='_blank'>Overexpression of HAAH in NIH-3T3 cells was        associated with generation of a malignant phenotype, and enzymatic activity was       required for cellular transformation.</br></a><font color='red'>enzymatic</font> <font color='blue'>for </font> <font color='green'>cellular transformation</font></p>",131,212,to,PREP,243
245,ASPH gene,metaplastic cell transformation,ASSOCIATED_WITH,<p><a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=10728685' target='_blank'>These findings suggest that overexpression        of HAAH is linked to cellular transformation of biliary epithelial cells.</br></a><font color='red'>HAAH</font> <font color='blue'>linked </font> <font color='green'>cellular transformation</font></p>,130,212,to,VERB,244
